Global Chronic Myelogenous Leukemia Therapeutics Market 2024-2028
상품코드:1581796
리서치사:TechNavio
발행일:2024년 10월
페이지 정보:영문 146 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
만성 골수성 백혈병 치료제 시장(2024-2028년)
만성 골수성 백혈병 치료제 시장은 2023-2028년 19억 3,550만 달러 규모에 달할 것으로 예상되며, 예측 기간 동안 5.6%의 CAGR로 성장할 것으로 예상됩니다. 만성 골수성 백혈병 치료제 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.
현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 새로운 치료법의 등장, tkis의 환자 지원 프로그램, 전략적 제휴 등이 시장을 주도하고 있습니다.
시장 범위
기준 연도
2024
종료 연도
2028
예측 기간
2024-2028
성장 모멘텀
가속
전년 대비 2024년
5.2%
CAGR
5.6%
증분 금액
19억 3,550만 달러
이 보고서는 파이프라인 분자의 출현이 향후 몇 년간 만성 골수성 백혈병 치료제 시장 성장을 견인하는 주요 요인 중 하나라고 분석했습니다. 또한, 진단 테스트 및 예측 마커의 시장 개척과 재생의료 분야의 연구 증가가 시장의 큰 수요를 창출할 것으로 예상했습니다.
The chronic myelogenous leukemia therapeutics market is forecasted to grow by USD 1935.5 mn during 2023-2028, accelerating at a CAGR of 5.6% during the forecast period. The report on the chronic myelogenous leukemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advent of novel therapies, patient assistance programs for tkis, and strategic alliances.
Market Scope
Base Year
2024
End Year
2028
Series Year
2024-2028
Growth Momentum
Accelerate
YOY 2024
5.2%
CAGR
5.6%
Incremental Value
$1935.5 mn
Technavio's chronic myelogenous leukemia therapeutics market is segmented as below:
By Product
Targeted therapy
Chemotherapy
Immunotherapy
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the emergence of pipeline molecules as one of the prime reasons driving the chronic myelogenous leukemia therapeutics market growth during the next few years. Also, development of diagnostic tests and predictive markers and increasing research in regenerative medicines will lead to sizable demand in the market.
The report on the chronic myelogenous leukemia therapeutics market covers the following areas:
Chronic Myelogenous Leukemia Therapeutics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading chronic myelogenous leukemia therapeutics market vendors that include Amneal Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Innovent Biologics Inc., Lupin Ltd., Merck KGaA, Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Sheba Medical Center, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the chronic myelogenous leukemia therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Chronic Myelogenous Leukemia Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Chronic Myelogenous Leukemia Therapeutics Market 2018 - 2022 ($ million)
